|
| |
| | | 67742 | | 08.10.2021 | | Janssen-Cilag AG | | | | | | | 07.10.2026 | | | | | | 08.03. | | | | 08.03. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | REKAMBYS 600 mg / 2 ml | Depot-Injektionssuspension | Depot-Injektionssuspension (Rilpivirinum 600mg / 2ml) | J05AG05 | | | 02 | REKAMBYS 900 mg / 3 ml | Depot-Injektionssuspension | Depot-Injektionssuspension (Rilpivirinum 900mg / 3ml) | J05AG05 | |
|
|
|
